ALS and Motor Neuron Disease in Kathmandu — Early Signs and Supportive Care

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a progressive neurodegenerative condition affecting both upper and lower motor neurons. It causes muscle weakness, atrophy, and eventually respiratory failure. While there is no cure, early diagnosis enables comprehensive supportive care that improves quality of life and survival.

Early symptoms often begin asymmetrically. Limb-onset ALS presents with weakness in one arm or leg — difficulty with fine motor tasks (buttoning, writing), foot drop, or reduced grip strength. Bulbar-onset ALS affects speech and swallowing first — slurred speech, difficulty chewing or swallowing, and emotional lability (inappropriate laughing or crying). Many patients initially notice muscle cramps, fasciculations (twitching), or stiffness before recognisable weakness develops.

Dr. Jitendra Prasad Yadav — consultant neurologist & headache specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for peripheral neuropathy.

Diagnosis requires excluding other conditions that mimic ALS. Evaluation includes detailed neurological examination, electromyography (EMG) and nerve conduction studies to confirm motor neuron involvement, blood tests to rule out mimics (vitamin B12 deficiency, thyroid disease, paraproteinemia), and MRI of the brain and spinal cord to exclude structural causes. The diagnosis is clinical and based on the presence of both upper motor neuron signs (spasticity, hyperreflexia) and lower motor neuron signs (weakness, atrophy, fasciculations) in multiple body regions.

Treatment approaches include riluzole, which modestly slows disease progression, and edaravone, which may slow functional decline in some patients. More importantly, comprehensive multidisciplinary care significantly improves outcomes. Respiratory support includes regular pulmonary function testing and non-invasive ventilation when respiratory muscles weaken. Nutritional support involves early dietitian assessment and consideration of feeding tube placement when swallowing becomes unsafe. Physiotherapy maintains mobility and prevents contractures. Speech therapy addresses communication difficulties.

Psychological support for patients and families is essential. Depression and anxiety are common reactions to the diagnosis. Advance care planning should be discussed early, allowing patients to express their wishes regarding ventilation, feeding, and end-of-life care while they can still communicate.

At Kathmandu Neurology Clinic & Cognitive Center, Dr. Jitendra Prasad Yadav (NMC 8029) provides ALS evaluation and coordinates multidisciplinary care at Durbar Marg, Opposite of Yak & Yeti Hotel. The emphasis is on early diagnosis, comprehensive supportive care, and maintaining quality of life for as long as possible.

This article is educational and does not replace individual medical advice.

**Frequently Asked Questions**

Q: What causes ALS? A: Most ALS cases are sporadic with no clearly identified cause. About 5-10% are familial, associated with genetic mutations such as C9orf72, SOD1, and FUS. Environmental factors being studied include smoking, military service, and certain occupations, but no single cause has been proven.

Q: How fast does ALS progress? A: Disease progression varies significantly between individuals. Average survival from symptom onset is 3-5 years, but approximately 20% of patients live 5-10 years, and about 10% live more than 10 years. Age at onset, bulbar involvement, and respiratory function influence prognosis.

Q: Is ALS hereditary? A: About 5-10% of ALS cases are familial, meaning they run in families. The remaining 90-95% are sporadic, occurring without a clear family history. Genetic testing may be considered when there is a strong family history or when the diagnosis is uncertain.

Q: What are the warning signs of ALS? A: Warning signs include progressive muscle weakness that worsens over weeks to months, muscle cramps and twitching, difficulty with fine motor tasks, slurred speech, difficulty swallowing, and stumbling or tripping. When these symptoms occur without pain and involve multiple body regions, neurological evaluation is warranted.

Q: Can ALS be prevented? A: There is no known way to prevent ALS. Research continues into potential risk factors and protective factors, but currently, there are no proven prevention strategies. Early diagnosis and comprehensive supportive care remain the mainstay of management.

Q: What support is available for ALS patients in Nepal? A: Support includes neurology evaluation, physiotherapy, speech therapy, nutritional support, respiratory care, and psychological counselling. Family education and caregiver support are essential components of care. Advance care planning helps ensure patient wishes are respected.